Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Median Sales Estimate At $59.155


The EPS projection of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) for quarter ended 2016-09-30 is $0.18. Last week, the EPS forecast was $0.18 against target of $0.18, a month earlier. Two months ago, this estimate was $0.18 versus forecast of $0.18 three months earlier, implying a deviation of 0%.

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) stated that 18 days ago, its stock price was positively revised 0 times while negative revisions were 2.

In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 1, 3, and 3, correspondingly.

EPS estimate downgrade for Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) in the preceding 30, 120, 60 and 90 days were 0, 2, 2, and 2, correspondingly.

Earnings Surprises

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) EPS target for the quarter closed 1 was $0.18, based on 5 recommendations. As reported on 2016-05-03 the EPS was $0.08. The change was $0, implying a percentage deviation of 0%. The projections showed a standard deviation of 0.02.

Quarterly Sales Estimates

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) yearly sales prediction for the fiscal 2016 stands at $59.89 and the median estimate is at $59.155. Almost 4 analysts issued sales target.

Highest sales target is $63.8 while the lowest target is $57.45 showing standard deviation of 2.863%.

As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.

Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0%.

A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) announced that the deviation in forecast was -0.321%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 2 times, 1 visits today)